Randomized controlled trial of a brief behavioural intervention for reducing hepatitis C virus risk practices among injecting drug users
- PMID: 15317636
- DOI: 10.1111/j.1360-0443.2004.00809.x
Randomized controlled trial of a brief behavioural intervention for reducing hepatitis C virus risk practices among injecting drug users
Abstract
Aim: To develop and evaluate a brief intervention for reducing risk behaviours associated with HCV transmission in injecting drug users (IDU).
Design: Randomized controlled trial of an individually tailored brief behavioural intervention (BBI) (experimental) versus a standardized educational intervention (control).
Setting: Specialist drug treatment facility in Melbourne, Australia.
Participants: One hundred and forty-five IDU (aged 18 or over, injecting at least weekly in the preceding 6 months) recruited and randomized to the experimental condition (n = 73) or the control condition (n = 72).
Interventions: The BBI was based on the Blood-Borne Virus Transmission Risk Assessment Questionnaire (BBV-TRAQ)-a standardized blood-borne virus risk assessment instrument comprising injecting risk, sexual risk and other skin penetration risk subscales. The BBV-TRAQ was used to identify individual HCV risk practices and to tailor the 30-minute experimental BBI. Control participants received a standardized HCV educational session, using current educational materials.
Main outcome measures: BBV-TRAQ subscale and total scores and measures of participant satisfaction.
Results: One hundred and twenty-four participants (86%) were followed-up at 4 weeks (+/-7 days). Analyses revealed a significant reduction in HCV risk behaviours for both groups at 1-month follow-up, with participants in the experimental BBI condition reporting higher overall satisfaction with the intervention compared to the control group.
Conclusions: Both groups reported significant reductions in risk behaviour, indicating that while BBI methods hold promise for HCV education and prevention, they were not demonstrated to be more effective than the provision of standard educational materials. Future research could evaluate the efficacy of the BBV-TRAQ as a risk behaviour intervention and counselling tool in clinical, NSP and peer education settings.
Similar articles
-
A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users.AIDS. 2007 Sep 12;21(14):1923-32. doi: 10.1097/QAD.0b013e32823f9066. AIDS. 2007. PMID: 17721100 Clinical Trial.
-
Assessment of risky injection practices associated with hepatitis B, hepatitis C, and human immunodeficiency virus and using the blood-borne virus transmission risk assessment questionnaire.J Addict Dis. 2012;31(1):80-8. doi: 10.1080/10550887.2011.642755. J Addict Dis. 2012. PMID: 22356671
-
Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT).Drug Alcohol Depend. 2007 Nov;91 Suppl 1:S4-17. doi: 10.1016/j.drugalcdep.2007.05.007. Epub 2007 Jun 19. Drug Alcohol Depend. 2007. PMID: 17582705 Clinical Trial.
-
Controlled evaluation of a brief intervention for HIV prevention among injecting drug users not in treatment.AIDS Care. 1994;6(5):559-70. doi: 10.1080/09540129408258670. AIDS Care. 1994. PMID: 7711089 Clinical Trial.
-
The social production of hepatitis C risk among injecting drug users: a qualitative synthesis.Addiction. 2008 Oct;103(10):1593-603. doi: 10.1111/j.1360-0443.2008.02306.x. Addiction. 2008. PMID: 18821870 Review.
Cited by
-
Characterizing and improving HIV and hepatitis knowledge among primary prescription opioid abusers.Drug Alcohol Depend. 2013 Dec 1;133(2):625-32. doi: 10.1016/j.drugalcdep.2013.08.007. Epub 2013 Aug 30. Drug Alcohol Depend. 2013. PMID: 24051063 Free PMC article. Clinical Trial.
-
Quantifying hepatitis C transmission risk using a new weighted scoring system for the Blood-Borne Virus Transmission Risk Assessment Questionnaire (BBV-TRAQ): applications for community-based HCV surveillance, education and prevention.Harm Reduct J. 2008 Apr 23;5:12. doi: 10.1186/1477-7517-5-12. Harm Reduct J. 2008. PMID: 18433470 Free PMC article.
-
Expanding the continuum of substance use disorder treatment: Nonabstinence approaches.Clin Psychol Rev. 2022 Feb;91:102110. doi: 10.1016/j.cpr.2021.102110. Epub 2021 Nov 26. Clin Psychol Rev. 2022. PMID: 34864497 Free PMC article. Review.
-
Development of a risk reduction intervention to reduce bacterial and viral infections for injection drug users.Subst Use Misuse. 2013 Jan;48(1-2):54-64. doi: 10.3109/10826084.2012.722159. Epub 2012 Sep 27. Subst Use Misuse. 2013. PMID: 23017057 Free PMC article.
-
Psychosocial interventions for reducing injection and sexual risk behaviour for preventing HIV in drug users.Cochrane Database Syst Rev. 2010 Jan 20;2010(1):CD007192. doi: 10.1002/14651858.CD007192.pub2. Cochrane Database Syst Rev. 2010. PMID: 20091623 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical